1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc.

INBS
Intelligent Bio Solutions Inc.US flagNASDAQ Capital Market
2.44
USD
-0.10
- -
1.58MMarket Cap

Total Valuation

Intelligent Bio Solutions Inc. carries a market capitalization of 1.58M, placing it among publicly traded companies globally. Its enterprise value stands at -1.43M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.58M
Enterprise Value-1.43M

Share Statistics

Intelligent Bio Solutions Inc. currently has 2.00M shares outstanding.

Shares Outstanding2.00M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.97, and the price-to-book ratio stands at -0.05.

PE RatioN/A
PS Ratio0.97
PB Ratio-0.05
P/TBV Ratio0.66
P/FCF Ratio-0.36
P/OCF Ratio-0.35

Enterprise Valuation

EV / Sales5.51
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Intelligent Bio Solutions Inc. maintains a current ratio of 2.11, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 21.12, indicating elevated leverage, while an interest coverage ratio of -134.22 demonstrates limited ability to service its debt obligations.

Current Ratio2.11
Quick Ratio1.80
Debt / Equity21.12
Debt / EBITDA-0.19
Interest Coverage-134.22

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-95.01
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.22

Stock Price Statistics

Intelligent Bio Solutions Inc.'s stock has declined approximately -84.75% over the past 52 weeks. The 50-day moving average sits at 2.83, while the 200-day moving average is 7.70.

Beta (5Y)N/A
52-Week Price Change-84.75%
50-Day Moving Average2.83
200-Day Moving Average7.70
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Intelligent Bio Solutions Inc. generated 3.91M in revenue and converted that into -11.61M in net income, yielding earnings per share of -10.28. EBITDA reached -9.99M, while operating income came in at -11.17M.

Revenue3.91M
Gross Profit1.85M
Operating Income-11.17M
Pretax Income-11.65M
Net Income-11.61M
EBITDA-9.99M
EBIT-11.17M
Earnings Per Share (EPS)-10.28

Balance Sheet

Intelligent Bio Solutions Inc. holds 6.86M in cash and equivalents against 1.85M in total debt, resulting in a net debt position of -6.86M. Total book value stands at -71.04M, with working capital of 5.14M providing operational flexibility.

Cash & Cash Equivalents6.86M
Total Debt1.85M
Net Debt-6.86M
Equity (Book Value)-71.04M
Book Value Per Share-62.68
Working Capital5.14M

Cash Flow

Intelligent Bio Solutions Inc. produced -10.95M in operating cash flow over the past twelve months. After subtracting -334,248.00 in capital expenditures, free cash flow totaled -11.29M - equivalent to -9.96 per share.

Operating Cash Flow-10.95M
Capital Expenditures-334,248.00
Free Cash Flow-11.29M
FCF Per Share-9.96

Margins

Intelligent Bio Solutions Inc. operates with a gross margin of 47.25, reflecting its pricing power and cost economics. The operating margin of -285.44 and net profit margin of -296.77 provide insight into operational efficiency.

Gross Margin47.25
Operating Margin-285.44
Pretax Margin-297.80
Profit Margin-296.77
EBITDA Margin-255.24

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-402.29
FCF Yield-279.73

Stock Splits

Intelligent Bio Solutions Inc.'s most recent stock split took place on December 16, 2025 with a 10:1 split ratio.

Last Split Date12/16/2025
Split Ratio10:1

Scores

Intelligent Bio Solutions Inc. posts an Altman Z-Score of -10.27, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-10.27